logo

For the Inventor, By the Inventor

Malvern, PA, United States of America

Phasebio Pharmaceuticals, Inc.


USPTO Granted Patents = 12



Trademarks = 1

Forward Citations = 32

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Susan Arnold (6 out of 6 patents)

silverMedal Lynne Georgopoulos (5 out of 5 patents)

bronzeMedal David James Ballance (4 out of 5 patents)

4.  Suzanne Dagher (3 out of 7 patents)

5.  Christopher M Yates (2 out of 46 patents)

6.  Steven Sparks (2 out of 7 patents)

7.  Andrew J Turner (2 out of 15 patents)

8.  Homayoun Sadeghi (2 out of 2 patents)

9.  Sammy Ray Shaver (2 out of 31 patents)

10.  James Jowett (1 out of 1 patent)

11.  Christopher Prior (1 out of 1 patent)

12.  William Joel Hoekstra (1 out of 81 patents)

13.  Lynne M Georgopoulos (0 patent)

14.  Lynne M Georgopoulos (0 patent)

15.  Andrew Turner (0 patent)


12 patents:

1. 11266719 - Methods and compositions for treating muscle disease and disorders (2022-03-08),
2. 11136309 - Metalloenzyme inhibitor compounds (2021-10-05),
3. 11052132 - Methods and compositions for treating cystic fibrosis (2021-07-06),
4. 11040034 - Metalloenzyme inhibitor compounds (2021-06-22),
5. 10940182 - Use of modified vasoactive intestinal peptides in the treatment of hypertension (2021-03-09),
6. 10722590 - ELP fusion proteins for controlled and sustained release (2020-07-28),
7. 10688156 - Methods and compositions for treating muscle disease and disorders (2020-06-23),
8. 9919032 - Method for administering a sustained release formulation (2018-03-20),
9. 9700598 - Modified vasoactive intestinal peptides (2017-07-11),
10. 9561262 - Use of modified vasoactive intestinal peptides in the treatment of hypertension (2017-02-07),
11. 9029505 - Modified vasoactive intestinal peptides (2015-05-12),
12. 7709227 - Multimeric ELP fusion constructs (2010-05-04),
Company Overview
PhaseBio Pharmaceuticals, Inc. is a biopharmaceutical company based in Malvern, Pennsylvania, focused on developing innovative therapies for rare diseases. The company specializes in protein-based therapeutics, leveraging its proprietary technology platforms to create novel treatments that address unmet medical needs. With a commitment to advancing patient care, PhaseBio is engaged in research and development efforts that aim to improve the lives of individuals affected by serious health conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

12 Patents

#32 in Malvern, PA

#930 in Pennsylvania

#25,578 in US

#48,209 in the World

Malvern, PA (US)
Malvern, PA, United States of America

Phasebio Pharmaceuticals, Inc.

Forward Citations = 32

12 inventors:

goldMedal Susan Arnold (6 out of 6 patents)

silverMedal Lynne Georgopoulos (5 out of 5 patents)

bronzeMedal David James Ballance (4 out of 5 patents)

4.  Suzanne Dagher (3 out of 7 patents)

5.  Christopher M Yates (2 out of 46 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Phasebio Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/phasebio-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…